Please provide your email address to receive an email when new articles are posted on . Risk for late feeding tube dependence was low and did not differ between intensity-modulated radiation therapy ...

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...

SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...

Please provide your email address to receive an email when new articles are posted on . Men with low- or intermediate-risk prostate cancer achieved similar quality-of-life outcomes whether they ...

Patient-reported outcomes (PROs) in the C-POST trial of adjuvant cemiplimab (cemi) vs placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC). Efficacy analysis of neoadjuvant PD-1 ...

HB-200 arenavirus-based immunotherapy plus pembrolizumab as first-line treatment of patients with recurrent/metastatic HPV16-positive head and neck cancer: Updated results. This is an ASCO Meeting ...

March 2023 marks the 10th Anniversary of the proton therapy facility. Thank you to all our dedicated patients, doctors and staff who've made this place what it is today. Also, learn more about the ...

The irradiation station at the Bronowice Cyclotron Center. PhD student Paulina Stasica-Dudek from the Institute of Nuclear Physics of the Polish Academy of Sciences presents the detector used to ...

Mission Complete: Mevion Medical Systems to showcase the MEVION S250-FIT Proton Therapy System TM, a revolutionary patient-centric proton therapy solution designed to FIT in a conventional LINAC vault ...

LITTLETON, Mass. & MORRISTOWN, N.J.--(BUSINESS WIRE)--Atlantic Health System, an integrated health care system setting standards for quality health care in New Jersey, Pennsylvania and the New York ...